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Continuous wavelet transform (CWT) was proposed for the simultaneous determination and dissolution 
profiles of valsartan (VAL) and hydrochlorothiazide (HCT) in tablets, without the use of a chemical 
separation procedure. The CWT approach was applied to the original UV spectra and their ratio spectra 
in the optimal wavelength ranges. After testing several wavelet families, Mexican hat function-CWT 
and Daubechies7-CWT (mexh-CWT and db7-CWT, respectively) were found to be suitable for the 
transformation of the original UV spectra. In the following procedure, mexh-CWT and Coiflets3-CWT 
(coif3-CWT) were found to be appropriate for the signal analysis of ratio spectra (RS) of VAL/HCT and 
HCT/VAL. Calibration graphs for VAL and HCT were obtained by measuring db7-CWT and mexh-CWT 
amplitudes in the transformation of the original absorption spectra and RS-coif-CWT and RS-mexh-
CWT amplitudes in the transformation of the ratio spectra. The validity and applicability of the proposed 
CWT methods were evaluated through the analysis of an independent set of synthetic binary mixtures 
consisting of VAL and HCT. The proposed signal processing methods were then successfully applied 
to the simultaneous quantitative evaluation and simultaneous dissolution profiles of the related drugs in 
commercial tablets, with good agreement reported for the experimental results. 
Uniterms: Spectral Continuous Wavelets Transform. Valsartan. Hydrochlorothiazide. Binary mixture/
tablets.
INTRODUCTION
The simultaneous analysis and simultaneous 
dissolution testing of combined pharmaceutical 
formulations are key issues in contemporary analytical 
chemistry and pharmaceutical technology due to the 
interference of the spectral bands within the same region, 
or due to unresolved chromatographic peaks of compounds 
that have similar chemical and physical properties. In 
experimental applications, the aforementioned problems 
have been solved through the use of several analytical 
techniques such as derivative spectrophotometry and high 
performance liquid chromatography (HPLC). In some 
cases, a classical derivative technique – or its modified 
version – may not yield successful outcomes due to the 
presence of overlapping spectral bands, the interference 
of the main band with noise peaks, and the complexity 
caused by the matrix effect of commercial samples. On 
the other hand, HPLC and its hyphenated approaches are 
more specific than classical derivative spectrophotometry, 
but they are also more expensive. In addition, determining 
optimal experimental conditions in HPLC analysis is time 
consuming and requires the excessive use of a reactive. In 
this study, we propose that new analytical methods such as 
powerful signal processing and chemometric calibrations 
are able to overcome the analytical problems involved in 
multicomponent analysis without the introduction of any 
separation step. In this context, wavelets are powerful tools 
that can eliminate the drawbacks of classical analytical 
methods.
Wavelet transform (WT) is considered to be one 
of the most efficient signal analysis tools used today 
(Daubechies, 1992; Walczak, 2000). The WT approach is 
categorised into two classes: discrete wavelets transform 
(DWT) and continuous wavelets transform (CWT). CWT 
has often been used for the elimination of the noise effect, 
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the resolution of overlapping spectral characteristics, and 
baseline correction. The development and application 
of the CWT approaches has extensively increased the 
potential power of spectral analysis methods for resolving 
multicomponent mixtures (Shao, Zhuang, 2004). Very 
recently, the CWT method combined with the zero-
crossing technique and ratio signal treatments has been 
reported to yield positive results for the simultaneous 
quantitative analysis of multicomponent pharmaceutical 
preparations and other samples (Dinç, Baleanu, Üstündağ, 
2003; Dinç, Baleanu 2007; Pektaş, Dınç, Baleanu, 2009). 
In signal transformation, wavelets provide a higher signal/
noise ratio than the classical derivative approach with 
zero-crossing. Another advantage of the wavelet transform 
method over the derivative technique is that it contains 
rich wavelet families for the resolution of overlapping 
spectral bands (Dinç, Baleanu, Üstündağ, 2003; Dinç, 
Baleanu, 2007).
The combination of VAL and HCT has been 
widely used in commercial pharmaceuticals due to their 
respective antihypertensive and diuretic properties. The 
combination of valsartan (an angiotensin II type 1 [AT(1)] 
receptor blocker) and hydrochlorothiazide (a thiazide 
diuretic), administered once daily, has been evaluated 
in the treatment of patients with hypertension in clinical 
trials ranging in duration from 8 weeks to 3 years. These 
studies showed that combination treatment with valsartan 
80mg or 160 mg and hydrochlorothiazide 12.5 mg or 25 
mg induced significant reductions from baseline systolic 
blood pressure (SBP) and diastolic blood pressure (DBP) 
in patients with mild to severe hypertension. Clinical trials 
have demonstrated that the combination of valsartan 80 
mg/160 mg with hydrochlorothiazide 12.5 mg/25 mg is 
significantly more effective than the administration of 
either drug alone (Wellington et al., 2002).
Several analytical methods have been adopted for 
the quantitative estimation of VAL and its combination 
with other drugs in pharmaceuticals and biological fluids, 
including spectrophotometry (Dinç, Uslu, Özkan, 2004; 
Mohamed, 2011; Gupta et al., 2010; Ramachandran, 
Mandal, Navalgund, 2011), multivariate calibration 
(Dinç, Uslu, Özkan, 2004), HPLC (Carlucci, Carlo, 
Mazzeo, 2000; Tian et al., 2008; Zarghi et al., 2008; 
Sudesh, Uttamrao, 2009; Vinzuda, Saılor, Sheth, 2010; 
Vignaduzzo, Castellano, Kaufman, 2011; Rao, Nıkalje, 
2014), UPLC (Antil et al., 2013), TLC (Ramadan, Al-
Akraa, Maktabi, 2014), HPTLC (Shah et al., 2009), 
voltammetry (Erden et al., 2014) and LC-MS (Li et al., 
2007). Additionally, the use of CWT methods has been 
reported for the determination of other mixtures (Ashour 
et al., 2015; Abbasi, 2016).
The main aim of this study is to develop and apply 
new signal processing methods for the simultaneous 
spectral determination and simultaneous dissolution tests 
of VAL and HCT drugs in tablets. In the application of 
CWT to the original UV spectra and the corresponding 
ratio spectra, various wavelet families at different scale 
factors (a), were tested. Here, the use of db7-CWT 
(a=240) and mexh-CWT (a=100) for the transformation 
of the original UV spectra was found to be suitable for 
VAL and HCT analysis. In addition, RS-coif3-CWT 
(a=290 for VAL and a=360 for HCT) and RS-mexh-
CWT (a=56 for both VAL and HCT) were found to 
be optimal for the transformation of the ratio spectra 
of related drugs. As a comparison method, traditional 
derivative spectrophotometry was subjected to analysis 
and dissolution assays. All of the proposed methods 
were validated through the use of various synthetic 
binary mixtures and the standard addition technique. The 
satisfactory results obtained through the application of 
the proposed signal processing tools to the simultaneous 
quantitative prediction and simultaneous dissolution 
monitoring of the target drugs are reported. 
MATERIAL AND METHODS
Instruments and Software
The UV spectra was performed on a Shimadzu UV-
160 double beam UV–Vis spectrophotometer possessing 
a fixed slit width (2 nm) connected to a computer loaded 
with Shimadzu UVPC software. Spectral data processing, 
statistical calculations and spectral transformation 
procedure were performed using MS Excel and the 
wavelet toolbox in Matlab software. 
The USP paddle method (Apparatus II) was used 
for the dissolution rate studies at 37±0.5 ºC (AYMES 
dissolution test apparatus, Aymes Ind., Umraniye, 
Istanbul, Turkey). The dissolution rate test was 
performed at 50 rpm in a 900 mL phosphate buffer 
solution at pH 6.8 (USP 27). All formulations were 
tested for 20 minutes. Sink conditions were maintained 
during all measurements. The dissolution test procedure 
was performed through the use of six experiments. The 
absorption spectra of the samples were plotted between 
200 nm and 360 nm. The proposed signal processing 
CWT methods were applied to the absorption spectra of 
the related dissolution samples. 
Commercial tablet
The commercial pharmaceutical under study was 
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the Co-Diovan film-coated tablet (NOVARTIS Pharm. 
Ind., Istanbul, Turkey), consisting of 80 mg VAL and 12.5 
mg HCT per tablet. Active compounds VAL and HCT 
were kindly denoted from national pharm. industry firms 
in Turkey.
Standard calibration solutions
The standard stock solutions of VAL and HCT were 
prepared by dissolving 25 mg of each drug in 100 mL 
of the phosphate buffer solution, consisting of KH2PO4 
at pH= 6.8 (USP 30, 2008). The solvent type used as 
an analytical blank to zero for the spectrometer was a 
phosphate buffer solution consisting of KH2PO4 at pH= 
6.8 (USP 30, 2008). The calibration solutions of VAL and 
HCT, in the range of 1.0-33.0 µg/mL and 1.0-26.0 µg/mL, 
were obtained from the prepared stock solutions. Method 
applicability and validity testing of the proposed methods 
were carried out using a validation sample set consisting of 
VAL and HCT in the aforementioned linear concentration 
ranges prepared using the same stock solutions. 
RESULTS AND DISCUSSION
The absorption spectra of the calibration solutions 
of VAL and HCT in the concentration ranges 1-33 µg/mL 
and 1-26 µg/mL were recorded between 200-360 nm, 
respectively. The absorption spectra of samples were 
plotted in the same way. The overlapping absorption 
spectra of VAL and HCT compounds and their tablet 
sample are depicted in Figure 1, which demonstrates that 
conventional spectrophotometric approaches do not allow 
for the simultaneous quantitative analysis and simultaneous 
dissolution tests of VAL and HCT in their tablets. This is 
due to the strong overlapping of spectral bands. In this 
case, a chromatographic method or a separation procedure 
must be used for the quantitative resolution of a two-
component mixture. Given the expensive components and 
time-consuming nature of the chromatographic separation 
techniques, we focused primarily on the development and 
application of the new signal processing method - wavelets 
- for rapid, precise, accurate and economic analysis and 
dissolution testing of tablets containing VAL and HCT drugs 
without the use of a separation step.
Here, the CWT approach combined with the zero-
crossing technique and ratio treatments of signals were 
improved for the quantification and dissolution profiles 
of VAL and HCT in the commercial tablets. In order to 
compare the results provided by CWT methods, the first 
derivative spectrophotometry (DS1) was subjected to the 
same problem. 
CWT-zero crossing method
In the application of the CWT signal processing tool, 
the standard calibration solutions of pure VAL and pure 
HCT substances between 1.0-33.0 µg/mL and 1.0-26.0 µg/
mL were separately prepared in 25 mL calibrated flasks 
through the use of the phosphate buffer solution consisting 
of KH2PO4 (pH= 6.8). The UV spectra of the standard 
calibration solutions of the subjected compounds with 
their corresponding tablet solutions were recorded (see 
Figure 1). The one-dimensional data vectors of the UV 
spectra of the calibration and samples were then transferred 
into Microsoft Excel. The transferred absorbance data 
vectors were processed using the wavelet toolbox in 
Matlab 7.10. Next, several continuous wavelet families 
at different scale parameters (a) were tested to determine 
the optimal CWT method for achieving the best recovery 
in the analysis of the related compounds. As part of this 
process, the selectivity and sensitivity of the analysis were 
measured by changing the spectral region (200-360 nm). 
We concluded that db7-CWT (a=240) and mexh-CWT 
(a=100) provided optimal signal transformation of the 
original UV spectra to obtain the highest recovery results. 
In addition, db7-CWT and mexh-CWT were applied to 
the VAL and HCT absorption spectra for the analysis 
and dissolution tests of both compounds, consisting of 
512 data points and corresponding to wavelength ranges 
of 230.0-281.1 nm and 235.0-286.1 nm, respectively. 
In the following step, db7-CWT and mexh-CWT 
spectra were obtained by plotting the CWT-coefficients 
(C(a,b)) against the wavelengths. The CWT spectra of 
FIGURE 1 - The UV spectra of VAL (----) : 1.0, 3.0, 9.0, 15.0, 
21.0, 27.0, 33.0 µg/mL and HCT () : 1.0, 6.0, 11.0, 16.0, 21.0, 
26.0 µg/mL and tablet sample () containing 2.50 µg/mL of 
VAL and 16.0 µg/mL of HCT in pH 6.8 phosphate buffer. 
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Ratio spectra-CWT method
The UV absorption spectra of VAL and HCT in 
the calibration series of 1.0-33.0 µg/mL and 1.0-26.0 
µg/mL were recorded against a blank (phosphate buffer 
solution, pH= 6.8). This procedure was then repeated for 
the samples (see Figure 1). A total of 1,024 data points in 
the spectral region of 220.0-322.3 nm were considered for 
the CWT application. 
For the VAL ratio spectra treatments, the standard 
FIGURE 2A - db7-CWT spectra of VAL (----) : 1.0, 3.0, 9.0, 15.0, 
21.0, 27.0, 33.0 µg/mL and HCT () : 1.0, 6.0, 11.0, 16.0, 21.0, 
26.0 µg/mL and tablet sample () containing 2.50 µg/mL of 
VAL and 16.0 µg/mL of HCT.
FIGURE 2B - mexh-CWT spectra of VAL (----) : 1.0, 3.0, 9.0, 
15.0, 21.0, 27.0, 33.0 µg/mL and HCT () : 1.0, 6.0, 11.0, 16.0, 
21.0, 26.0 µg/mL and tablet sample () containing 2.50 µg/mL 
of VAL and 16.0 µg/mL of HCT.
TABLE I - Linear least square analysis and statistical results
 
db7-CWT mexh-CWT RS-coif3-CWT RS-mexh-CWT
DS1
a= 240 a= 240 a= 100 a= 100 a= 290 a= 360 a= 56 a= 56
VAL HCT VAL HCT VAL HCT VAL HCT VAL HCT
λ(nm) 244.7 273.7 256.8 270.4 242.0 320.0 242.3 325.0 265.8 242.5
Range 1.0-33.0 1.0-26.0 1.0-33.0 1.0-26.0 1.0-33.0 1.0-26.0 1.0-33.0 1.0-26.0 1.0-33.0 1.0-26.0
m -0.0666 -0.3456 0.1357 0.5042 2.0707 2.2904 1.8116 0.7124 -0.0100 0.0242
n -0.0160 0.0232 0.0268 -0.0512 0.6038 -0.0331 0.8209 -0.0477 -0.0015 0.0064
r 0.9990 0.9992 0.9996 0.9989 0.9999 0.9999 0.9999 0.9999 0.9999 0.9997
SE(m) 0.0020 0.0079 0.0016 0.0116 0.0118 0.0191 0.0117 0.0061 0.0001 0.0003
SE(n) 0.0376 0.1207 0.0314 0.1357 0.2261 0.3050 0.2249 0.0968 0.0192 0.0316
SE(r) 0.0581 0.1658 0.0485 0.2432 0.3492 0.3994 0.3474 0.1267 0.0019 0.0058
LOD 0.16 0.31 0.05 0.27 0.18 0.30 0.21 0.10 0.27 0.30
LOQ 0.52 1.03 0.18 0.89 0.60 0.99 0.68 0.32 0.90 1.01
m: Slope of the straight-line; n: y-intercept of the straight line; SE: Standart error; LOD: The limit of detection; LOQ: The limit 
of quantitation.
compounds and their tablet samples are illustrated in 
Figures 2a and 2b. 
In order to determine the amount of VAL and HCT 
in the tablets and plot the simultaneous dissolution profiles 
of the related drugs, the calibration graphs for both drugs 
were obtained using linear regression analysis. This was 
based on the relationship between concentration and 
CWT-coefficients at 244.7 nm (VAL) and 273.7 nm (HCT) 
for db7-CWT and 256.8 nm (VAL) and 270.4 nm (HCT) 
for mexh-CWT. The linear regression analysis and its 
statistical outputs are presented in Table I.
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spectra of HCT at different concentrations were tested in 
order to determine the optimal divisor concentration. As a 
result, the standard spectrum corresponding to the solution 
of 16 µg/mL HCT was found to be suitable to obtain the 
ratio spectra (RS) of VAL and its binary mixtures. As 
described above, the UV spectra of VAL in its binary 
mixtures were divided by the standard divisor spectrum 
of HCT and the corresponding ratio spectra were obtained 
as indicated in Figure 3a. 
In the next step, several CWT families at different 
scaling factors (a) were applied to the ratio spectra, 
providing the elimination of HCT for the quantification 
of VAL in the samples. It was observed that RS-coif3-
CWT (a=290) and RS-mexh-CWT (a=56) were found to 
be suitable for the analysis of VAL in samples containing 
HCT. The RS-coif3-CWT and RS-mexh-CWT spectra 
of VAL were obtained by plotting the coif3-CWT and 
mexh-CWT coefficients of the VAL ratio spectra against 
wavelengths, as illustrated in Figures 3b and 3c.
Taking into account the above signal processing 
conditions, the linear calibration equations for VAL were 
obtained by measuring the RS-coif3-CWT and RS-mexh-
CWT amplitudes at 242.0 and 242.3 nm, corresponding to 
maxima (see Figures 3b and 3c). Linear regression analysis 
and the corresponding statistical data for the application of 
both RS-coif3-CWT and RS-mexh-CWT are summarised 
in Table I. The determination and dissolution profiles of 
VAL in tablets containing HCT were carried out through 
the aforementioned linear calibration equations. 
Similarly, standard spectra of VAL at different 
divisor concentrations were used to determine the 
optimal ratio spectra of HCT. Following the above testing 
procedure, the ratio spectra of HCT and its binary mixtures 
were obtained by dividing the original absorption spectra 
by the standard spectrum of 27 µg/mL VAL. The resulting 
ratio spectra are presented in Figure 4a. 
After applying different continuous wavelet 
families to the ratio spectra, coif3-CWT (a=360) and 
mexh-CWT (a=56) tools were found to be optimal for the 
transformation of the ratio spectra of HCT and its samples 
containing VAL. The ratio spectra-CWT procedures in the 
application of coif3-CWT and mexh-CWT to the ratio 
spectra of the HCT standard calibration series and tablet 
FIGURE 3A - Ratio spectra of VAL/HCT, VAL (----) : 1.0, 
3.0, 9.0, 15.0, 21.0, 27.0, 33.0 µg/mL and HCT () : 1.0, 6.0, 
11.0, 16.0, 21.0, 26.0 µg/mL and tablet sample () containing 
2.50 µg/mL of VAL and 16.0 µg/mL of HCT.
FIGURE 3B - RS-coif3-CWT spectra of VAL (----) : 1.0, 3.0, 9.0, 
15.0, 21.0, 27.0, 33.0 µg/mL and HCT () : 1.0, 6.0, 11.0, 16.0, 
21.0, 26.0 µg/mL and tablet sample () containing 2.50 µg/mL 
of VAL and 16.0 µg/mL of HCT.
FIGURE 3C - RS-mexh-CWT spectra of VAL (----) : 1.0, 3.0, 
9.0, 15.0, 21.0, 27.0, 33.0 µg/mL and HCT () : 1.0, 6.0, 11.0, 
16.0, 21.0, 26.0 µg/mL and tablet sample () containing 2.50 
µg/mL of VAL and 16.0 µg/mL of HCT.
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sample were denoted using the RS-coif3-CWT and RS-
mexh-CWT methods. The RS-coif3-CWT spectra and RS-
mexh-CWT spectra of HCT and its tablet were obtained by 
plotting the CWT coefficients of the ratio spectra against 
wavelengths, as shown in Figures 4b and 4c, respectively.
For the analysis of HCT in samples containing VAL, 
the concentration of HCT was proportional to the RS-
coif3-CWT and RS-mexh-CWT amplitudes at 320.0 and 
325.0 nm, respectively corresponding to the wavelength 
maxima (see Figures 4b and 4c). Based on the relationship 
between concentration and the RS-coif3-CWT and RS-
mexh-CWT signals, least square regression analysis and 
its statistical outputs were collected (see Table I). The 
concentration of HCT in binary mixtures were calculated 
using the linear regression equations.
Derivative spectrophotometry
For derivative spectrophotometry (DS), the first 
derivative spectra of VAL and HCT in the concentration 
ranges of 1.0-33.0 µg/mL and 1.0-26.0 µg/mL, respectively, 
were calculated by processing the original UV spectra in 
the wavelength region of 230.0-300.0 nm. The spectral 
derivative calculation was performed using intervals of 
∆λ=10 nm and scaling factor=10. Figure 5 illustrates the 
first derivative spectra of the standard calibration series for 
VAL and HCT, and the tablet sample. This first derivative 
spectrophotometry is abbreviated as DS1. 
In the application of the DS1 approach, two 
calibration graphs for VAL and HCT were obtained by 
measuring the derivative intensity at 265.8 nm (which 
corresponds to a zero-crossing point for VAL) and 242.5 
nm (which corresponds to a zero-crossing point for HCT) 
in the original spectral wavelength range of 230.0-300.0 
nm, respectively. Calibration graphs and their statistical 
data are depicted in Table I. These calibration graphs were 
applied to the quantitative evaluation and the plot profiles 
of VAL and HCT in their tablets.
Analytical validation of the signal processing 
methods
During the method validation process, a number of 
FIGURE 4A - A) Ratio spectra of HCT/VAL, VAL (----) : 1.0, 
3.0, 9.0, 15.0, 21.0, 27.0, 33.0 µg/mL and HCT () : 1.0, 6.0, 
11.0, 16.0, 21.0, 26.0 µg/mL and tablet sample () containing 
2.50 µg/mL of VAL and 16.0 µg/mL of HCT.
FIGURE 4B - RS-coif3-CWT spectra of VAL (----) : 1.0, 3.0, 
9.0, 15.0, 21.0, 27.0, 33.0 µg/mL and HCT () : 1.0, 6.0, 11.0, 
16.0, 21.0, 26.0 µg/mL and tablet sample () containing 2.50 
µg/mL of VAL and 16.0 µg/mL of HCT.
FIGURE 4C - RS-mexh-CWT spectra of VAL (----) : 1.0, 3.0, 
9.0, 15.0, 21.0, 27.0, 33.0 µg/mL and HCT () : 1.0, 6.0, 11.0, 
16.0, 21.0, 26.0 µg/mL and tablet sample () containing 2.50 
µg/mL of VAL and 16.0 µg/mL of HCT.
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analytical validation parameters were defined by range, 
linearity, accuracy, precision, selectivity, limit of detection 
(LOD) and limit of quantitation (LOQ). These factors were 
used to demonstrate the performance and applicability 
of the proposed signal processing methods (db7-CWT, 
mexh-CWT, RS-coif3-CWT, RS-mexh-CWT and DS1) 
for the quantification and dissolution tests of VAL and 
HCT in tablets.
The concentration ranges of 1.0-33.0 µg/mL for 
VAL and 1.0-26.0 µg/mL for HCT were found to be 
suitable for the analysis of the related drugs, with good 
linearity reported for the calculated calibration graphs 
of VAL and HCT based on the application of db7-CWT, 
mexh-CWT, RS-coif3-CWT, RS-mexh-CWT and DS1 
under optimised experimental conditions and method 
settings (see Table I). 
The accuracy and precision of the proposed methods 
were tested using 13 replicate determinations at different 
concentration levels containing binary mixtures. In this 
study, percentage mean recoveries and their relative 
standard deviations (RSDs) were computed and are 
presented in Table II. We concluded that the numerical 
values indicate satisfactory accuracy and precision with 
good reproducibility for the application of all of proposed 
signal processing tools. It was observed that the mean 
recovery results and RSDs provided by the CWT signal 
processing approaches appeared to be a little higher than 
those of DS1 method (see Table II). 
Standard deviations of linear regression line 
intercepts and their corresponding slopes were used in 
order to calculate the limit of detection (LOD; signal-
FIGURE 5 - First derivative spectra of VAL (----) : 1.0, 3.0, 9.0, 
15.0, 21.0, 27.0, 33.0 µg/mL and HCT () : 1.0, 6.0, 11.0, 16.0, 
21.0, 26.0 µg/mL and tablet sample () containing 2.50 µg/mL 
of VAL and 16.0 µg/mL of HCT.
TABLE II - Recovery data of VAL and HCT in the synthetic mixtures by applying the signal processing methods
 
Mixture
Found (µg/mL) and Recovery (%)
db7-CWT mexh-CWT RS-coif3-CWT RS-mexh-CWT
DS1
(a= 240) (a= 240) (a= 100) (a= 100) (a= 290) (a= 360) (a= 56) (a= 56)
VAL  HCT VAL HCT VAL HCT VAL HCT VAL HCT VAL HCT
16 1 16,2 101 1,0 103 15,5 96,8 1,0 99,1 15,7 97,8 1,0 102 15,4 96,5 1,0 99,4 15,3 95,9 1,0 95,3
16 6 15,7 97,8 6,2 103 15,6 97,4 6,2 103 15,4 96,4 5,9 97,9 16 99,9 6,0 99,9 15,8 98,5 6,1 102
16 11 16,3 102 11,1 101 15,7 98,1 11,2 102 15,3 95,7 10,9 98,7 16 100 10,9 99,3 15,1 94,3 10,5 95,5
16 16 16,1 101 16,2 101 16,1 101 16,2 101 16 99,7 15,9 99,6 15,6 97,2 16,1 101 15,1 94,6 15,1 94,3
16 21 15,8 99 21,0 99,8 16,2 101 21,1 100 16,1 101 20,9 99,5 16,1 101 20,9 99,7 16,1 101 19,9 94,6
16 26 16,4 102 25,7 98,7 16,4 102 25,8 99,3 15,7 98 25,6 98,3 16,5 103 26 100 15,5 97,1 26,3 101
1 3 1,0 97 3,1 102 1,0 97 3,2 105 1,0 96,3 2,9 97,8 1,0 101 3,0 99,1 1,03 103 2,8 94
3 3 3,08 103 3,0 100 3,1 105 3 100 3,1 102 3,1 104 3,1 105 3,2 106 3,0 99,4 2,9 95,8
9 3 8,9 98,4 3,1 103 9,4 104 3,1 103 9,2 102 3,0 98,2 9,0 100 3,0 101 8,6 96 2,9 98,1
15 3 15,3 102 3,1 104 15,1 100 3,1 104 15 100 3,0 98,8 14,6 97,5 3,0 101 14,6 97,6 2,8 93,4
21 3 21,5 102 3,2 105 21,3 101 3,1 104 21,2 101 2,9 95,9 20,7 98,5 3,0 100 19,7 93,9 2,9 97,5
27 3 28,4 105 3,1 102 27,4 102 3,1 103 27,8 103 2,9 97 27,2 101 3,0 98,5 26,7 98,7 2,9 94,9
33 3 32,9 99,8 3,0 99,2 33,4 101 3,1 105 32,1 97,1 2,9 95,5 33,4 101 3,0 101 31,4 95,2 2,9 96,8
Mean 100,7 101,6 100,5 102,2 99,2 98,7 100,1 100,5 97,3 96,4
SD 2,25 1,87 2,53 2,10 2,44 2,26 2,27 1,84 2,76 2,62
  RSD 2,24  1,84  2,52  2,05  2,46  2,29  2,27  1,83  2,83  2,72
SD: Standard deviation; RSD: Relative standard deviation
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to-noise ratio of 3:1) and the limit of quantitation (LOQ; 
signal-to noise ratio of 10:1) in the applications of db7-
CWT, mexh-CWT, RS-coif3-CWT, RS-mexh-CWT and 
DS1. These results can be seen in Table I.
Tablet analysis and dissolution tests
In this investigation, five different signal processing 
methods (db7-CWT, mexh-CWT, RS-coif3-CWT, RS-
mexh-CWT and conventional DS1) were applied to the 
simultaneous quantitative analysis of VAL and HCT in 
tablets. Assay results are presented in Table III. 
The USP paddle method (Apparatus II) was used in 
dissolution rate studies (37±0.5ºC), which were performed 
in phosphate buffer solutions of pH= 6.8. The absorptions 
of the samples were plotted in the range of 200-360 nm. 
The proposed db7-CWT, mexh-CWT, RS-coif3-CWT, 
RS-mexh-CWT and DS1 were applied to the above spectra 
of the related dissolution samples. The release profiles of 
VAL and HCT were obtained by applying the proposed 
signal processing methods (see Figures 6a-b, Figures 
7a-b and Figure 8). We concluded that 80% of the VAL 
and HCT was released from the tablets within the first 5 
minutes.
TABLE III - Determination results of VAL and HCT in tablets by CWT methods 
mg/tablet
db7-CWT mexh-CWT RS-coif3-CWT RS-mexh-CWT DS1
(a= 240) (a= 240) (a= 100) (a= 100) (a= 290) (a= 360) (a= 56) (a= 56)
 VAL HCT VAL HCT VAL HCT VAL HCT VAL HCT
12.26 78.61 12.81 78.82 12.28 79.52 12.17 77.87 12.24 78.54
13.08 79.61 12.69 78.52 12.58 78.35 12.20 79.30 11.85 76.92
12.63 80.27 12.41 79.50 12.41 79.13 12.10 77.05 12.56 77.46
12.68 79.08 12.96 80.42 12.48 78.71 12.29 81.18 12.10 79.02
12.47 77.31 12.66 77.68 12.12 81.29 12.08 78.03 12.13 76.38
 12.69 79.86 13.09 79.46 12.71 80.25 11.98 80.54 11.99 76.92
Mean 12.63 79.12 12.77 79.07 12.43 79.54 12.14 78.99 12.14 77.54
SD 0.27 1.06 0.24 0.95 0.21 1.08 0.11 1.63 0.24 1.03
BSD 2.18 1.34 1.90 1.20 1.71 1.36 0.87 2.06 2.00 1.33
SE 0.11 0.43 0.10 0.39 0.09 0.44 0.04 0.66 0.10 0.42
CL 0.22 0.85 0.19 0.76 0.17 0.87 0.08 1.30 0.19 0.83
SD: Standard deviation; RSD: Relative standard deviation; SE: Standard error; CL: Confidential limit (p=0.05).
FIGURE 6A - Dissolution profiles of VAL and HCT obtained 
by applying db7-CWT method.
FIGURE 6B - Dissolution profiles of VAL and HCT obtained by 
applying mexh-CWT method.
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CONCLUSION
It is widely recognised that the simultaneous analysis 
and dissolution of multicomponent pharmaceutical 
preparation is a highly significant issue in analytical 
chemistry and pharmaceutical technology. Despite 
strong overlap in the spectral bands of VAL and HCT, 
the proposed signal processing methods provided us with 
better results regarding the simultaneous determination 
of the related drugs, and they also allowed for the 
simultaneous demonstration of the in-vitro behaviour of 
the analysed drugs from the commercial tablets. After 
analysis, it was concluded that the proposed CWT signal 
processing methods gave comparable results to the 
literature-based HPLC method (Vinzuda et al., 2010). 
Consequently, the proposed - CWT, mexh-CWT, RS-
coif3-CWT, RS-mexh-CWT and DS1 methods can be 
considered suitable for use in the quality control, routine 
analysis and simultaneous dissolution tests of tablets 
containing VAL and HCT drugs. 
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